Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Tandem Diabetes Successful IPO Quiet Period Expires Soon
Seeking Alpha
Wednesday, December 4, 2013 - 11:46am
tags:
devices, Tandem Diabetes, IPOs, insulin pumps, diabetes
Boehringer Ingelheim looks for a buyer for its troubled Bedford operation
Fierce Pharma
Wednesday, December 4, 2013 - 11:45am
tags:
drug manufacturing, Boehringer Ingelheim
Denmark's Genmab expands biotech collaboration with Janssen
Reuters
Wednesday, December 4, 2013 - 11:44am
tags:
Genmab, Janssen, Duobody antibodies
Unilife: A Look At The Novartis News
Seeking Alpha
Wednesday, December 4, 2013 - 11:43am
tags:
Unilife, Novartis
Teva Sees $3 Billion in 2020 Sales of Reformulated Drugs
Bloomberg
Wednesday, December 4, 2013 - 11:42am
tags:
Teva
How The Global Pharma Industry Will Shape Up In The Next 5 Years?
Seeking Alpha
Wednesday, December 4, 2013 - 11:38am
tags:
Bristol-Myers Squibb, GSK, JNJ, Ophthotech, Novartis, Regeneron, Roche, Sanofi
FDA Clears ARCA Bio To Start Landmark Personalized Medicine Clinical Trial
Seeking Alpha
Wednesday, December 4, 2013 - 11:10am
tags:
FDA, ARCA biopharma, personalized medicine, Gencaro
Roche teams with Molecular Partners on armed proteins in $1B-plus deal
Fierce Biotech
Wednesday, December 4, 2013 - 10:18am
tags:
Roche, Molecular Partners, DARPin
BioDelivery Sciences: Delivering Profits In 2014
Seeking Alpha
Wednesday, December 4, 2013 - 10:16am
tags:
BioDelivery Sciences, Bunavail, BEMA
St. Jude Medical launches another neurostim trial, hits 52-week high
Mass Device
Wednesday, December 4, 2013 - 9:26am
tags:
Neurostim, St. Jude Medical, devices
2014 Could Be A Big Year For Inovio, Merrimack, And NeoStem
Seeking Alpha
Wednesday, December 4, 2013 - 9:24am
tags:
Inovio, Merrimack Pharmaceuticals, NeoStem, VGX-3100, MM-398, AMR-001
The Medicines Company Acquires Rempex Pharmaceuticals
Yahoo
Wednesday, December 4, 2013 - 8:51am
tags:
The Medicines Company, M&A, Rempex Pharmaceuticals
Teva seeks deals to build drug portfolio, 2014 outlook next week
Reuters
Wednesday, December 4, 2013 - 8:48am
tags:
Teva
The Provenge Vaccine, A Hedge Fund Manager And The SEC
Pharmalot
Wednesday, December 4, 2013 - 8:47am
tags:
SEC, prostate cancer, Provenge, Dendreon
5 Blockbuster Drugs Going Off Patent in 2014
Motley Fool
Wednesday, December 4, 2013 - 8:38am
tags:
patents, Eli Lilly, Evista, Teva, Copaxone, Novartis, Exforge, Sandostatin LAR, Nexium, AstraZeneca
Teva and Takeda Announce Agreement for Glatiramer Acetate for Multiple Sclerosis Treatment in Japan
Yahoo
Wednesday, December 4, 2013 - 8:20am
tags:
Teva, Takeda, glatiramer acetate, Japan, MS, multiple sclerosis
3 Biggest FDA Decisions of 2013
Motley Fool
Wednesday, December 4, 2013 - 8:18am
tags:
FDA, Sarepta Therapeutics, drisapersen, Iclusig, Ariad Pharmaceuticals, Vascepa, Amarin
Vivus Needs Catalyst For Qsymia
Seeking Alpha
Wednesday, December 4, 2013 - 8:15am
tags:
Vivus, Qsymia, obesity
Report: AstraZeneca kicks tires on Forest, eyes multibillion-dollar deal
Fierce Biotech
Tuesday, December 3, 2013 - 7:24pm
tags:
M&A, Forest Labs, AstraZeneca
Investors cool on biotech IPOs as shares fall
Yahoo/AP
Tuesday, December 3, 2013 - 7:23pm
tags:
biotech, IPOs

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.